[1]Patent:US2005/282814,2005,A1
[1]Patent:US2007/259876,2007,A1.Locationinpatent:Page/Pagecolumn17
[1]Patent:US2007/259876,2007,A1.Locationinpatent:Page/Pagecolumn17
[1]JournalofMedicinalChemistry,2007,vol.50,p.4279-4294
[1]JournalofMedicinalChemistry,2007,vol.50,p.4279-4294
Title: PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases.
Journal: Journal of medicinal chemistry 20121025
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Journal: The Journal of pharmacology and experimental therapeutics 20090301
Title: Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction.
Journal: Journal of medicinal chemistry 20070906
Title: Doukas J, et al. Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19866-71.